• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于小型生物共轭物对用于诊疗应用的正电子发射体进行比较分析,重点关注钪、铜和钛。

Comparative analysis of positron emitters for theranostic applications based on small bioconjugates highlighting Sc, Cu and Ti.

作者信息

Hindié Elif, Köster Ulli, Champion Christophe, Zanotti-Fregonara Paolo, Morgat Clément

机构信息

Department of Nuclear Medicine, University Hospital of Bordeaux, Bordeaux, F-33076, France.

University of Bordeaux, UMR CNRS 5287, INCIA, Talence, F-33400, France.

出版信息

EJNMMI Phys. 2024 Nov 22;11(1):98. doi: 10.1186/s40658-024-00699-z.

DOI:10.1186/s40658-024-00699-z
PMID:39572444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11582248/
Abstract

BACKGROUND

Targeted radionuclide therapy with Lu-labelled small conjugates is expanding rapidly, and its success is linked to appropriate patient selection. Companion diagnostic conjugates are usually labelled with Ga, offering good imaging up to ≈2 h post-injection. However, the optimal tumor-to-background ratio is often reached later. This study examined promising positron-emitting radiometals with half-lives between 3 h and 24 h and β intensity (I) ≥ 15% and compared them to Ga. The radiometals included: Sc, Sc, Ti, Co, Cu, Cu, Ga, Y, Y, Nb, La, Tb and Tb. La (7.2% I) was also examined because it was recently discussed, in combination with La, as a possible diagnostic match for Ac.

METHODS

Total electron and photon doses per decay and per positron; possibly interfering γ-ray emissions; typical activities to be injected for same-day imaging; positron range; and available production routes were examined.

RESULTS

For each annihilation process useful for PET imaging, the total energy released (MeV) is: Ti (1.5), Sc (1.6), Cu and Cu (1.8), Ga (1.9), Sc and La (2.9), Co (3.2), Y (3.3), La (4.8), Tb (6.5), Tb (7.1), Nb (8.6), and Y (13.6). Significant amounts (≥ 10%) of ≈0.5 MeV photons that may fall into the acceptance window of PET scanners are emitted by Co, Ga, Y, Y, La, and Tb. Compton background from more energetic photons would be expected for Sc, Co, Ga, Y, Nb, La,Tb, and Tb. The mean positron ranges (mm) of Cu (0.6), Y (1.0), Ti (1.5), La (1.6), Sc and Cu (1.7), Co (2.1), Sc and Y (2.5), and Nb (2.6) were lower than that of Ga (3.6). DOTA chelation is applicable for most of the radiometals, though not ideal for Cu/Cu. Recent data showed that chelation of Ti with DOTA is feasible. Nb requires different complexing agents (e.g., DFO). Finally, they could be economically produced by proton-induced reactions at medical cyclotrons.

CONCLUSION

In particular, Sc, Ti, and Cu have overall excellent β decay-characteristics for theranostic applications complementing Lu-labelled small conjugates, and they could be sustainably produced. Like Lu, Sc, Ti and to a lesser extent Cu could be labelled with DOTA.

摘要

背景

用镥标记的小分子偶联物进行靶向放射性核素治疗正在迅速发展,其成功与合适的患者选择有关。伴随诊断偶联物通常用镓标记,在注射后约2小时内提供良好的成像。然而,最佳的肿瘤与背景比值通常在更晚的时候才能达到。本研究考察了半衰期在3小时至24小时之间且β射线强度(I)≥15%的有前景的正电子发射放射性金属,并将它们与镓进行比较。这些放射性金属包括:钪、钪、钛、钴、铜、铜、镓、钇、钇、铌、镧、铽和铽。还对镧(I为7.2%)进行了研究,因为最近有人讨论它与镥结合作为锕的一种可能的诊断配对物。

方法

研究了每次衰变和每个正电子的总电子和光子剂量;可能产生干扰的γ射线发射;同日成像所需注射的典型活度;正电子射程;以及可用的生产路线。

结果

对于PET成像有用的每个湮灭过程,释放的总能量(MeV)为:钛(1.5)、钪(1.6)、铜和铜(1.8)、镓(1.9)、钪和镧(2.9)、钴(3.2)、钇(3.3)、镧(4.8)、铽(6.5)、铽(7.1)、铌(8.6)和钇(13.6)。钴、镓、钇、钇、镧和铽会发射大量(≥10%)能量约为0.5 MeV的光子,这些光子可能落入PET扫描仪的接受窗内。钪、钴、镓、钇、铌、镧、铽和铽预计会产生来自能量更高光子的康普顿本底。铜(0.6)、钇(1.0)、钛(1.5)、镧(1.6)、钪和铜(1.7)、钴(2.1)、钪和钇(2.5)以及铌(2.6)的平均正电子射程(mm)低于镓(3.6)。DOTA螯合适用于大多数放射性金属,不过对铜/铜不太理想。最新数据表明钛与DOTA的螯合是可行的。铌需要不同的络合剂(如DFO)。最后,它们可以通过医用回旋加速器的质子诱导反应经济地生产出来。

结论

特别是,钪、钛和铜对于与镥标记的小分子偶联物互补的治疗诊断应用具有总体优异的β衰变特性,并且它们可以可持续生产。与镥一样,钪、钛以及程度稍低的铜可以用DOTA标记。

相似文献

1
Comparative analysis of positron emitters for theranostic applications based on small bioconjugates highlighting Sc, Cu and Ti.基于小型生物共轭物对用于诊疗应用的正电子发射体进行比较分析,重点关注钪、铜和钛。
EJNMMI Phys. 2024 Nov 22;11(1):98. doi: 10.1186/s40658-024-00699-z.
2
Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.用于放射治疗诊断的钪和铽放射性核素:临床应用的当前发展状况
Br J Radiol. 2018 Nov;91(1091):20180074. doi: 10.1259/bjr.20180074. Epub 2018 Jun 15.
3
First In Vivo and Phantom Imaging of Cyclotron-Produced La as a Theranostic Radionuclide for Ac and La.回旋加速器生产的镧作为放射性核素用于 Ac 和 La 的治疗诊断的首例体内和体模成像。
J Nucl Med. 2022 Apr;63(4):584-590. doi: 10.2967/jnumed.121.262459. Epub 2021 Aug 12.
4
3p-C-NETA: A versatile and effective chelator for development of AlF-labeled and therapeutic radiopharmaceuticals.3p-C-NETA:一种多功能、有效的螯合剂,可用于开发 AlF 标记的治疗放射性药物。
Theranostics. 2022 Aug 8;12(13):5971-5985. doi: 10.7150/thno.75336. eCollection 2022.
5
Clinical Translation and First In-Human Use of [Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer.[钪]Sc-PSMA-617用于转移性去势抵抗性前列腺癌PET成像的临床转化及首次人体应用
Theranostics. 2017 Sep 26;7(18):4359-4369. doi: 10.7150/thno.20586. eCollection 2017.
6
Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate.回旋加速器生产的 44Sc 作为三价 β-发射体诊断匹配物的承诺:44Sc-DOTA-叶酸缀合物的体外和体内研究。
J Nucl Med. 2013 Dec;54(12):2168-74. doi: 10.2967/jnumed.113.123810. Epub 2013 Nov 6.
7
Sc and Sc cross-section measurement for an optimized Sc production with an 18 MeV medical PET cyclotron.采用 18 MeV 医用 PET 回旋加速器优化钪生产的 Sc 和 Sc 截面测量。
Appl Radiat Isot. 2022 Nov;189:110428. doi: 10.1016/j.apradiso.2022.110428. Epub 2022 Aug 18.
8
Bone targeting compounds for radiotherapy and imaging: *Me(III)-DOTA conjugates of bisphosphonic acid, pamidronic acid and zoledronic acid.用于放射治疗和成像的骨靶向化合物:双膦酸、帕米膦酸和唑来膦酸的Me(III)-DOTA共轭物。
EJNMMI Radiopharm Chem. 2017;1(1):14. doi: 10.1186/s41181-016-0017-1. Epub 2016 Sep 23.
9
Cutting edge rare earth radiometals: prospects for cancer theranostics.前沿稀土放射性金属:癌症诊疗一体化的前景
EJNMMI Radiopharm Chem. 2022 Aug 26;7(1):21. doi: 10.1186/s41181-022-00173-0.
10
Cu production via the Zn(p,nα)Cu nuclear reaction: An untapped, cost-effective and high energy production route.通过 Zn(p,nα)Cu 核反应生产铜:一种未开发的、具有成本效益的高能生产途径。
Nucl Med Biol. 2024 Jan-Feb;128-129:108875. doi: 10.1016/j.nucmedbio.2024.108875. Epub 2024 Jan 6.

引用本文的文献

1
Decadentate Acyclic Chelators for Lanthanum Radiopharmaceuticals.用于镧放射性药物的十齿无环螯合剂。
J Med Chem. 2025 Aug 28;68(16):17823-17839. doi: 10.1021/acs.jmedchem.5c01558. Epub 2025 Aug 19.

本文引用的文献

1
Positronium image of the human brain in vivo.人体大脑正电子素成像。
Sci Adv. 2024 Sep 13;10(37):eadp2840. doi: 10.1126/sciadv.adp2840.
2
Positronium lifetime validation measurements using a long-axial field-of-view positron emission tomography scanner.使用长轴视野正电子发射断层扫描扫描仪进行正电子素寿命验证测量。
EJNMMI Phys. 2024 Aug 30;11(1):76. doi: 10.1186/s40658-024-00678-4.
3
Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging.铜(Cu)-PSMA 靶向 PET 用于前列腺癌:从示踪剂研发到首例人体成像。
J Nucl Med. 2024 Sep 3;65(9):1427-1434. doi: 10.2967/jnumed.123.267126.
4
Comparison of the dosimetry of scandium-43 and scandium-44 patient organ doses in relation to commonly used gallium-68 for imaging neuroendocrine tumours.钪-43和钪-44对患者器官剂量的剂量测定与常用于成像神经内分泌肿瘤的镓-68的比较。
EJNMMI Phys. 2024 Jul 15;11(1):61. doi: 10.1186/s40658-024-00669-5.
5
Synthesis and stability of the [Ti]Ti-DOTA complex: en route towards aza-macrocyclic Ti-based radiopharmaceuticals.[Ti]Ti-DOTA 配合物的合成与稳定性:迈向含氮大环 Ti 放射性药物。
Chem Commun (Camb). 2024 Jul 9;60(56):7148-7151. doi: 10.1039/d4cc01800a.
6
Cu-Labeled Radiotracers: Alternative or Choice?铜标记的放射性示踪剂:替代品还是选择?
J Nucl Med. 2023 Dec 1;64(12):1855-1857. doi: 10.2967/jnumed.123.266171.
7
Accelerator-Based Production of Scandium Radioisotopes for Applications in Prostate Cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics.基于加速器的镱放射性同位素生产用于前列腺癌应用:建立新型治疗药物快速开发的管道。
Molecules. 2023 Aug 13;28(16):6041. doi: 10.3390/molecules28166041.
8
Simultaneous quantitative imaging of two PET radiotracers via the detection of positron-electron annihilation and prompt gamma emissions.通过探测正电子-电子湮没和prompt gamma 辐射对两种 PET 示踪剂进行同时定量成像。
Nat Biomed Eng. 2023 Aug;7(8):1028-1039. doi: 10.1038/s41551-023-01060-y. Epub 2023 Jul 3.
9
Radiotheranostics in oncology: Making precision medicine possible.肿瘤放射治疗学:使精准医学成为可能。
CA Cancer J Clin. 2023 May-Jun;73(3):255-274. doi: 10.3322/caac.21768. Epub 2023 Jan 9.
10
Cu Treatment Planning and Cu Therapy with Radiolabeled [Cu/Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry.用放射性标记的[铜/铜]甲基环戊二烯基三羰基锝-奥曲肽对不可切除的多灶性脑膜瘤患者进行铜治疗计划和铜治疗:人体成像、安全性、生物分布和辐射剂量测定的初步结果
J Nucl Med. 2023 May;64(5):704-710. doi: 10.2967/jnumed.122.264586. Epub 2022 Dec 2.